We bring together talent and expertise from across the University of Minnesota to use stem cell biology to advance regenerative medicine therapies for devastating disorders and to provide education and training for the stem cell scientists of tomorrow.

Our Research

We depend on the variety of knowledge and expertise from faculty and departments across the University and beyond to pursue the collaborative goal of using stem cell technology to change the practice of regenerative medicine.

SCI scientists are making progress in finding treatments for spine and brain injury, heart damage, vision loss, diabetes, genetic disorders, cancer, and the need for organ and skin replacement. 


Our Education Programs

The bioscience and medical industries and academic research programs need intelligent, engaged, well-trained talent to fill jobs in the rapidly expanding field of regenerative medicine. The Stem Cell Institute prepares students who are ready to meet this need and who are eager to move the next generation of research forward. Learn more about our graduate programs:


Commercially Promising Stem Cell Research Projects Land State Funding

Last week, the 2018-2020 Research Awardees were announced by Regenerative Medicine Minnesota. Twin Cities Business picked up the story and highlighted the translational research award winners, two of whom (Drs. Lund and Tranquillo) are Stem Cell Institue faculty members. For the complete list of grant awards, please see www.regenmedmn.org.

SCI Happenings

Twenty Stem Cell Institute faculty, trainees, and employees spent six hours at the MN State Fair talking and playing games with fair goers who were interested in learning about the research and education that goes on in the Stem Cell Institute.

Weekly Research Conference

Exploiting the Developmental Organ Niche for Interspecies Organogenesis

Hiromitsu Nakauchi, MD/PhD
Department of Genetics
Institute for Stem Cell Biology and Regenerative Medicine
Stanford University
Stanford, CA

Wednesday, April 25, 2018 - 4:00pm
Improving Bone Marrow Transplant Outcomes through Non-Toxic Conditioning, Rapid Mobilization and HSC Expansion: Building the Transplant Medicines of the Future

Michael Cooke, PhD
Chief Scientific Officer
Magenta Therapeutics
Cambridge, MA

Wednesday, May 2, 2018 - 4:00pm